Literature DB >> 16845718

Bone marrow mesenchymal stem cell transplantation combined with perindopril treatment attenuates infarction remodelling in a rat model of acute myocardial infarction.

Jian-an Wang1, Rong-hua Luo, Xing Zhang, Xiao-jie Xie, Xin-yang Hu, Ai-na He, Jie Chen, Jia-hui Li.   

Abstract

OBJECTIVE: This study was performed to evaluate whether implantation of mesenchymal stem cell (MSC) would reduce left ventricular remodelling from the molecular mechanisms compared with angiotensin-converting enzyme inhibitors (ACEIs) perindopril into ischemic myocardium after acute myocardial infarction.
METHODS: Forty rats were divided into four groups: control, MSC, ACEI, MSC+ACEI groups. Bone marrow stem cell derived rat was injected immediately into a zone made ischemic by coronary artery ligation in MSC group and MSC+ACEI group. Phosphate-buffered saline (PBS) was injected into control group. Perindopril was administered p.o. to ACEI group and MSC+ACEI group. Six weeks after implantation, the rats were killed and heart sample was collected. Fibrillar collagen was observed by meliorative Masson's trichome stain. Western Blotting was employed to evaluate the protein expression of matrix metalloproteinase (MMP)-2, matrix metalloproteinase (MMP)-9 in infarction zone. The transcriptional level of MMP2, MMP9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1 in infarction area was detected by reverse transcriptase PCR (RT-PCR) analysis.
RESULTS: The fibrillar collagen area, the protein expression of MMP2, MMP9 and the transcriptional level of MMP2, MMP9 mRNA in infarction zone reduced in MSC group, ACEI group, and MSC+ACEI group. No significant difference was detected in the expression of TIMP1 mRNA among the 4 groups.
CONCLUSION: Both MSC and ACEI could reduce infarction remodelling by altering collagen metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845718      PMCID: PMC1533753          DOI: 10.1631/jzus.2006.B0641

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  17 in total

1.  Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice.

Authors:  L Roten; S Nemoto; J Simsic; M L Coker; V Rao; S Baicu; G Defreyte; P J Soloway; M R Zile; F G Spinale
Journal:  J Mol Cell Cardiol       Date:  2000-01       Impact factor: 5.000

Review 2.  Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction.

Authors:  D P Papadopoulos; E V Economou; T K Makris; K J Kapetanios; I Moyssakis; V E Votteas; P K Toutouzas
Journal:  Drugs Exp Clin Res       Date:  2004

Review 3.  Matrix metalloproteinases: regulation and dysregulation in the failing heart.

Authors:  Francis G Spinale
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

4.  Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism.

Authors:  Paul W M Fedak; Paul E Szmitko; Richard D Weisel; Svetlana M Altamentova; Nafiseh Nili; Nobuhisa Ohno; Subodh Verma; Shafie Fazel; Bradley H Strauss; Ren-Ke Li
Journal:  J Thorac Cardiovasc Surg       Date:  2005-10-13       Impact factor: 5.209

5.  Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

Authors:  D Reinhardt; H H Sigusch; J Hensse; S C Tyagi; R Körfer; H R Figulla
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

6.  Clinical significance of matrix metalloproteinases activity in acute myocardial infarction.

Authors:  D P Papadopoulos; I Moyssakis; T K Makris; M Poulakou; G Stavroulakis; D Perrea; V E Votteas
Journal:  Eur Cytokine Netw       Date:  2005-06       Impact factor: 2.737

7.  Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats.

Authors:  Xiaohua Xu; Zenglu Xu; Yuanyuan Xu; Guanghui Cui
Journal:  Coron Artery Dis       Date:  2005-06       Impact factor: 1.439

8.  Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta.

Authors:  Zhonglin Xie; Mahipal Singh; Krishna Singh
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.

Authors:  Jacob E Møller; Ulf Dahlström; Ole Gøtzsche; Avijit Lahiri; Knud Skagen; Gert Steen Andersen; Kenneth Egstrup
Journal:  Am Heart J       Date:  2004-03       Impact factor: 4.749

10.  Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction.

Authors:  Shao-liang Chen; Wu-wang Fang; Fei Ye; Yu-Hao Liu; Jun Qian; Shou-jie Shan; Jun-jie Zhang; Robert Zhao Chunhua; Lian-ming Liao; Song Lin; Jing-ping Sun
Journal:  Am J Cardiol       Date:  2004-07-01       Impact factor: 2.778

View more
  2 in total

1.  Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow.

Authors:  Jia-Hui Li; Peng Yang; Ai-Li Li; Yong Wang; Yuan-Nan Ke; Xian-Lun Li
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

2.  Comparative effects of bone marrow mesenchymal stem cells on lipopolysaccharide-induced microglial activation.

Authors:  Fan-Wei Tseng; May-Jywan Tsai; Li-Yu Yu; Yu-Show Fu; Wen-Cheng Huang; Henrich Cheng
Journal:  Oxid Med Cell Longev       Date:  2013-03-24       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.